Cosentyx missed its main goal in a Phase 3 GCA study, but showed lower steroid use. Novartis plans full review of the trial ...

Novartis NVS announced that a late-stage study of its interleukin-17A inhibitor, Cosentyx (secukinumab), has failed to meet ...

One is caused by inflamed arteries in the eye that flow to the optic nerve, ... giant cell arteritis. This is also known as inflammation of your blood vessels or temporal arteritis. Ischemic Optic ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant ...

SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck.

Optic atrophy involves vision loss due to damage affecting the optic nerve. Learn more about what causes ... This may include the management of cardiovascular disease or giant cell arteritis, ...

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA ...

With the exception of giant cell arteritis and hypertensive retinopathy, ... Posterior scleritis and optic nerve compression. Optic nerve compression requires urgent treatment.

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ® (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA ...

Diplopia should raise clinician suspicion for giant cell arteritis when associated with cephalic symptoms and prompt the use of corticosteroids to prevent ocular ischemic complications, according ...

Anterior ischemic optic neuropathy occurs when damage to the optic nerve results in vision loss. Learn more here. Health Conditions ... they will also want to rule out giant cell arteritis.

Source Reference: Denis G, et al "Diagnostic strategy using color Doppler ultrasound of temporal arteries in patients with high clinical suspicion of giant cell arteritis: a prospective cohort ...